Infection Control in Cystic Fibrosis

Clinical Microbiology Reviews

Volumn 17, Issue 1, 2004, Pages 57-71

  Saiman, Lisa ^a   Siegel, Jane ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM CULTURE; BRONCHUS SECRETION; BURKHOLDERIA CEPACIA; CLEANING; CYSTIC FIBROSIS; DISEASE TRANSMISSION; DISINFECTION; HEALTH CARE PERSONNEL; HUMAN; HYGIENE; INFECTION CONTROL; INFECTION RISK; NONHUMAN; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS;

CYSTIC FIBROSIS; GUIDELINE ADHERENCE; HUMANS; INFECTION CONTROL; RESPIRATORY TRACT INFECTIONS;

BACTERIA (MICROORGANISMS); BRONCHUS; BURKHOLDERIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA CEPACIA COMPLEX; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 1642556721     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.17.1.57-71.2004     Document Type: Review

References (204)

1. Abman, S. H., J. W. Ogle, N. Butler-Simon, C. M. Rumack, and F. J. Accurso. 1988. Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J. Pediatr. 113:826-830.
2. Abman, S. H., J. W. Ogle, R. J. Harbeck, N. Butler-Simon, K. B. Hammond, and F. J. Accurso. 1991. Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening. J. Pediatr. 119:211-217.
3. Aitken, M. L., W. Burke, G. McDonald, C. Wallis, B. Ramsey, and C. Nolan. 1993. Nontuberculous mycobacterial disease in adult cystic fibrosis patients. Chest 103:1096-1099.
4. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn. 1998. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. Pediatrics 102:1211-1216.
5. American Thoracic Society. 1997. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am. J. Respir. Crit. Care Med. 156:S1-S25.
6. Anderson, D. H. 1949. Therapy and prognosis of fibrocystic disease of the pancreas. Pediatrics 1949:406-417.
7. Aris, R. M., J. Routh, J. J. LiPuma, D. Heath, and P. H. Gilligan. 2001. Burkholderia cepacia complex in cystic fibrosis patients after lung transplantation: survival linked to genomovar type. Am. J. Respir. Crit. Care Med. 164:2102-2106.
8. Armstrong, D., K. Grimwood, J. B. Carlin, R. Carzino, J. Hull, A. Olinsky, and P. D. Phelan. 1998. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr. Pulmonol. 26:371-379.
9. Arnold, S. R., E. E. Wang, B. J. Law, F. D. Boucher, D. Stephens, J. L. Robinson, S. Dobson, J. M. Langley, J. McDonald, N. E. MacDonald, I. Mitchell, and the Pediatric Investigators Collaborative Network on Infections in Canada. 1999. Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Pediatr. Infect. Dis. J. 18:866-869.
10. Balandreau, J., V. Viallard, B. Cournoyer, T. Coenye, S. Laevens, P. Vandamme, and C. H. Pai. 2001. Burkholderia cepacia genomovar III Is a common plant-associated bacterium. Appl. Environ. Microbiol. 67:982-985.
11. Bange, F. C., B. A. Brown, C. Smaczny, R. J. Wallace, Jr., and E. C. Bottger. 2001. Lack of transmission of Mycobacterium abscessus among patients with cystic fibrosis attending a single clinic. Clin. Infect. Dis. 32:1648-1650.
12. Bargon, J., N. Dauletbaev, B. Kohler, M. Wolf, H. G. Posselt, and T. O. Wagner. 1999. Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients. Respir. Med. 93:835-838.
13. Bartley, J. 1996. Construction, p. 101-106. In R. N. Olmstead (ed.), Association for Professionals in Infection Control (APIC), infection control and applied epidemiology: principles and practice. Mosby Year Book Publications, St. Louis, Mo.
14. Bell, M., K. Seiber, M. Weatherly, and W. Jarvis. Infection control and the cystic fibrosis population: a survey of prevailing practices. Infect. Control Hosp. Epidemiol, in press.
15. Bernhardt, S. A., T. Spilker, T. Coffey, and J. J. LiPuma. 2003. Burkholderia cepacia complex in cystic fibrosis: frequency of strain replacement during chronic infection. Clin. Infect. Dis. 37:780-785.
16. Berrouane, Y. F., L. A. McNutt, B. J. Buschelman, P. R. Rhomberg, M. D. Sanford, R. J. Hollis, M. A. Pfaller, and L. A. Herwaldt. 2000. Outbreak of severe Pseudomonas aeruginosa infections caused by a contaminated drain in a whirlpool bathtub. Clin. Infect. Dis. 31:1331-1337.
17. Best, M., S. A. Sattar, V. S. Springthorpe, and M. E. Kennedy. 1988. Comparative mycobactericidal efficacy of chemical disinfectants in suspension and carrier tests. Appl. Environ. Microbiol. 54:2856-2858.
18. Bevivino, A., C. Dalmastri, S. Tabacchioni, L. Chiarini, M. L. Belli, S. Plana, A. Materazzo, P. Vandamme, and G. Manno. 2002. Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J. Clin. Microbiol. 40:846-851.
19. Bolyard, E. A., O. C. Tablan, W. W. Williams, M. L. Pearson, C. N. Shapiro, S. D. Deitchmann, and the Hospital Infection Control Practices Advisory Committee. 1998. Guideline for infection control in healthcare personnel, 1998. Infect. Control Hosp. Epidemiol. 19:407-463.
20. Bosshammer, J., B. Fiedler, P. Gudowius, H. von der Hardt, U. Romling, and B. Tummler. 1995. Comparative hygienic surveillance of contamination with pseudomonads in a cystic fibrosis ward over a 4-year period. J. Hosp. Infect. 31:261-274.
21. Botzenhart, K., and G. Doring. 1993. Epidemiology and ecology of Pseudomonas aeruginosa, p. 1-18. In M. Campa, M. Bendinelli, and H. Friedman (ed.), Pseudomonas aeruginosa as an opportunistic pathogen. Plenum Press, New York, N.Y.
22. Boxerbaum, B., M. R. Jacobs, and R. L. Cechner. 1988. Prevalence and significance of methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. Pediatr. Pulmonol. 4:159-163.
23. Boyce, J. M., and D. Pittet. 2002. Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. Morb. Mortal. Wkly. Rep. Recomm. Rep. 51:1-45, quiz CE41-CE44.
24. Boyce, J. M., and D. Pittet. 2001. Hand hygiene and patient care: pursuing the Semmelweis legacy. Lancet Infect. Dis. 2001:9-20.
25. Branger, C., C. Gardye, and N. Lambert-Zechovsky. 1996. Persistence of Staphylococcus aureus strains among cystic fibrosis patients over extended periods of time. J. Med. Microbiol. 45:294-301.
26. Bridges, C. B., K. Fukuda, T. M. Uyeki, N. J. Cox, and J. A. Singleton. 2002. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. Recomm. Rep. 51:1-31.
27. Brown, K., M. Rosenthal, and A. Bush. 1999. Fatal invasive aspergillosis in an adolescent with cystic fibrosis. Pediatr. Pulmonol. 27:130-133.
28. Burdge, D. R., E. M. Nakielna, and M. A. Noble. 1993. Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Infect. Control Hosp. Epidemiol. 14:127-130.
29. Burns, J. L., J. Emerson, J. R. Stapp, D. L. Yim, J. Krzewinski, L. Louden, B. W. Ramsey, and C. R. Clausen. 1998. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin. Infect. Dis. 27:158-163.
30. Burns, J. L., J. M. Van Dalfsen, R. M. Shawar, K. L. Otto, R. L. Garber, J. M. Quan, A. B. Montgomery, G. M. Albers, B. W. Ramsey, and A. L. Smith. 1999. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J. Infect. Dis. 179:1190-1196.
31. Carson, L. A., M. S. Favero, W. W. Bond, and N. J. Petersen. 1973. Morphological, biochemical, and growth characteristics of Pseudomonas cepacia from distilled water. Appl. Microbiol. 25:476-483.
32. Cefai, C., J. Richards, F. K. Gould, and P. McPeake. 1990. An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection of ventilatory equipment. J. Hosp. Infect. 15:177-182.
33. Centers for Disease Control. 1993. Centers for Disease Control: Pseudomonas cepacia at summer camps for persons with cystic fibrosis. Morb. Mortal. Wkly. Rep. 42:456-459.
34. Centers for Disease Control. 1994. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities. Morb. Mortal. Wkly. Rep. 43(RR-13):1-132.
35. Centers for Disease Control. 1994. Guidelines for prevention of nosocomial pneumonia. Respir. Care 39:1191-1236.
36. Chaix, C., I. Durand-Zaleski, C. Alberti, and C. Brun-Buisson. 1999. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 282:1745-1751.
37. Chen, J. S., K. Witzmann, T. Spilker, R. Fink, and J. J. LiPuma. 2001. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J. Pediatr. 139:643-649.
38. Cheng, K., R. L. Smyth, J. R. Govan, C. Doherty, C. Winstanley, N. Denning, D. P. Heaf, H. van Saene, and C. A. Hart. 1996. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 348:639-642.
39. Cimon, B., J. Carrere, J. F. Vinatier, J. P. Chazalette, D. Chabasse, and J. P. Bouchara. 2000. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur. J. Clin. Microbiol. Infect. Dis. 19:53-56.
40. Coenye, T., and J. LiPuma. 2002. Population structure analysis of Burkholderia cepacia genomovar III: varying degrees of genetic recombination characterize major clonal complexes. Microbiology 149:77-88.
41. Corey, M., and V. Farewell. 1996. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am. J. Epidemiol. 143:1007-1017.
42. Reference deleted.
43. Cullen, A. R., C. L. Cannon, E. J. Mark, and A. A. Colin. 2000. Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection? Am. J. Respir. Crit. Care Med. 161:641-645.
44. Cystic Fibrosis Foundation. Cystic Fibrosis Consensus Conference May 17-18, 1994. Microbiology and infectious disease in cystic fibrosis, vol. V, Sect. 1, p. 1-26. Cystic Fibrosis Foundation, Bethesda, Md.
45. Cystic Fibrosis Foundation. 1996. Cystic Fibrosis Foundation patient registry 1995. Cystic Fibrosis Foundation, Bethesda, Md.
46. Cystic Fibrosis Foundation. 1997. Cystic Fibrosis Foundation patient registry 1996. Cystic Fibrosis Foundation, Bethesda, Md.
47. Cystic Fibrosis Foundation. 1998. Cystic Fibrosis Foundation patient registry 1997. Cystic Fibrosis Foundation, Bethesda, Md.
48. Cystic Fibrosis Foundation. 1999. Cystic Fibrosis Foundation patient registry 1998. Cystic Fibrosis Foundation, Bethesda, Md.
49. Cystic Fibrosis Foundation. 2000. Cystic Fibrosis Foundation patient registry 1999. Cystic Fibrosis Foundation, Bethesda, Md.
50. Cystic Fibrosis Foundation. 2001. Cystic Fibrosis Foundation patient registry 2000. Cystic Fibrosis Foundation, Bethesda, Md.
51. Cystic Fibrosis Foundation. 2002. Cystic Fibrosis Foundation patient registry 2001. Cystic Fibrosis Foundation, Bethesda, Md.
52. Demko, C. A., R. C. Stern, and C. F. Doershuk. 1998. Stenotrophomonas maltophilia in cystic fibrosis: incidence and prevalence. Pediatr. Pulmonol. 25:304-308.
53. Denton, M., N. J. Todd, K. G. Kerr, P. M. Hawkey, and J. M. Littlewood. 1998. Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples. J. Clin. Microbiol. 36:1953-1958.
54. De Soyza, A., A. McDowell, L. Archer, J. H. Dark, S. J. Elborn, E. Mahenthiralingam, K. Gould, and P. A. Corris. 2001. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 358:1780-1781.
55. Doring, G., S. Jansen, H. Noll, H. Grupp, F. Frank, K. Botzenhart, K. Magdorf, and U. Wahn. 1996. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward. Pediatr. Pulmonol. 21:90-100.
56. Doring, G., M. Ulrich, W. Muller, J. Bitzer, L. Schmidt-Koenig, L. Munst, H. Grupp, C. Wolz, M. Stern, and K. Botzenhart. 1991. Generation of Pseudomonas aeruginosa aerosols during handwashing from contaminated sink drains, transmission to hands of hospital personnel, and its prevention by use of a new heating device. Zentbl. Hyg. Umweltmed. 191:494-505.
57. Drabick, J. A., E. J. Gracely, G. J. Heidecker, and J. J. LiPuma. 1996. Survival of Burkholderia cepacia on environmental surfaces. J. Hosp. Infect. 32:267-276.
58. Dunne, W. M., Jr., and S. Maisch. 1995. Epidemiological investigation of infections due to Alcaligenes species in children and patients with cystic fibrosis: use of repetitive-element-sequence polymerase chain reaction. Clin. Infect. Dis. 20:836-841.
59. Dy, M. E., J. A. Nord, V. J. LaBombardi, J. Germana, and P. Walker. 1999. Lack of throat colonization with Burkholderia cepacia among cystic fibrosis healthcare workers. Infect. Control Hosp. Epidemiol. 20:90.
60. Ensor, E., H. Humphreys, D. Peckham, C. Webster, and A. J. Knox. 1996. Is Burkholderia (Pseudomonas) cepacia disseminated from cystic fibrosis patients during physiotherapy? J. Hosp. Infect. 32:9-15.
61. Fabbri, A., A. Tacchella, G. Manno, C. Viscoli, C. Palmero, and G. F. Gargani. 1987. Emerging microorganisms in cystic fibrosis. Chemioterapia 6:32-37.
62. Farrell, P. M., G. Shen, M. Splaingard, C. E. Colby, A. Laxoya, M. R. Kosorok, M. J. Rock, and E. H. Mischler. 1997. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics 100:E2.
63. Favero, M. S., L. A. Carson, W. W. Bond, and N. J. Petersen. 1971. Pseudomonas aeruginosa: growth in distilled water from hospitals. Science 173:836-838.
64. Ferson, M. J., J. R. Morton, and P. W. Robertson. 1991. Impact of influenza on morbidity in children with cystic fibrosis. J. Paediatr. Child Health. 27:308-311.
65. Fiorillo, L., M. Zucker, D. Sawyer, and A. N. Lin. 2001. The pseudomonas hot-foot syndrome. N. Engl. J. Med. 345:335-338.
66. Fluge, O., B. Ojeniyi, N. Hoiby, A. Digranes, O. Ciofu, E. Hunstad, O. C. Haanaes, and O. T. Storrosten. 2001. Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients. Clin. Microbiol. Infect. 7:238-243.
67. Foca, M., K. Jakob, S. Whittier, P. Della-Latta, S. Factor, D. Rubenstein, and L. Saiman. 2000. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. N. Engl. J. Med. 343:695-700.
68. Frederiksen, B., C. Koch, and N. Hoiby. 1999. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr. Pulmonol. 28:159-166.
69. Fung, S. K., H. Dick, H. Devlin, and E. Tullis. 1998. Transmissibility and infection control implications of Burkholderia cepacia in cystic fibrosis. Can. Infect. Dis. J. 9:177-182.
70. Garner, J. S., for The Hospital Infection Control Practices Advisory Committee. 1996. Guideline for isolation precautions in hospitals. Infect. Control Hosp. Epidemiol. 17:53-80.
71. Geller, D. E., H. Kaplowitz, M. J. Light, A. A. Colin, and Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis. 1999. Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Chest 116:639-646.
72. Gern, J. E., and W. W. Busse. 1999. Association of rhinovirus infections with asthma. Clin. Microbiol. Rev. 12:9-18.
73. Givney, R., A. Vickery, A. Holliday, M. Pegler, and R. Benn. 1997. Methicillin-resistant Staphylococcus aureus in a cystic fibrosis unit. J. Hosp. Infect. 35:27-36.
74. Goerke, C., K. Kraning, M. Stern, G. Doring, K. Botzenhart, and C. Wolz. 2000. Molecular epidemiology of community-acquired Staphylococcus aureus in families with and without cystic fibrosis patients. J. Infect. Dis. 181:984-989.
75. Gonzalez, C. F., G. L. Mark, E. Mahenthiralingam, and J. J. LiPuma. 2000. Isolation of soilborne genomovar III Burkholderia cepacia and lytic phages with inter-genomovar host range. Pediatr. Pulmonol. S20:288-289.
76. Govan, J. R., P. H. Brown, J. Maddison, C. J. Doherty, J. W. Nelson, M. Dodd, A. P. Greening, and A. K. Webb. 1993. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342:15-19.
77. Govan, J. R., and J. W. Nelson. 1992. Microbiology of lung infection in cystic fibrosis. Br. Med. Bull. 48:912-930.
78. Gross, P. A., C. R. Denning, P. F. Gaerlan, J. Bonelli, M. Bernius, S. Dran, G. Monk, M. Vassallo, G. V. Quinnan, Jr., R. Levandowski, P. E. Cataruozolo, and S. Wallenstein. 1996. Annual influenza vaccination: immune response in patients over 10 years. Vaccine 14:1280-1284.
79. Grothues, D., U. Koopmann, H. von der Hardt, and B. Tummler. 1988. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J. Clin. Microbiol. 26:1973-1977.
80. Gruber, W. C., P. W. Campbell, J. M. Thompson, G. W. Reed, B. Roberts, and P. F. Wright. 1994. Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study. J. Infect. Dis. 169:241-247.
81. Gurevich, I., P. Tafuro, P. Ristuccia, J. Herrmann, A. R. Young, and B. A. Cunha. 1983. Disinfection of respirator tubing: a comparison of chemical versus hot water machine-assisted processing. J. Hosp. Infect. 4:199-208.
82. Hamill, R. J., E. D. Houston, P. R. Georghiou, C. E. Wright, M. A. Koza, R. M. Cadle, P. A. Goepfert, D. A. Lewis, G. J. Zenon, and J. Clarridge. 1995. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann. Intern. Med. 122:762-766.
83. Healthcare Infection Control Practices Advisory Committee (HICPAC). 2001. Guidelines for environmental infection control in healthcare facilities, 2001. Centers for Disease Control and Prevention, Atlanta, Ga.
84. Health, D., K. Hohneker, C. Carriker, K. Smith, J. Routh, J. LiPuma, R. M. Aris, D. Weber, and P. Gilligan. 2002. Six-year molecular analysis of Burkholderia cepacia complex isolates among cystic fibrosis patients at a referral center for lung transplantation. J. Clin. Microbiol. 40:1188-1193.
85. Henry, R. L., C. M. Mellis, and L. Petrovic. 1992. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr. Pulmonol. 12:158-161.
86. Hiatt, P. W., S. C. Grace, C. A. Kozinetz, S. H. Raboudi, D. G. Treece, L. H. Taber, and P. A. Piedra. 1999. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics 103:619-626.
87. Hjelt, K., N. Hojlyng, P. Howitz, N. Illum, E. Munk, N. H. Valerius, K. Fursted, K. N. Hansen, I. Heltberg, and C. Koch. 1994. The role of mycobacteria other than tuberculosis (MOTT) in patients with cystic fibrosis. Scand. Infect. Dis. 26:569-576.
88. Hoffmann, K. K., D. J. Weber, and W. A. Rutala. 1989. Pseudo epidemic of Rhodotorula rubra in patients undergoing fiberoptic bronchoscopy. Infect. Control Hosp. Epidemiol. 10:511-514.
89. Hoiby, N., and S. S. Pedersen. 1989. Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients. Acta Paediatr. Scand. 78:395-404.
90. Holmes, A., R. Nolan, R. Taylor, R. Finley, M. Riley, R. Z. Jiang, S. Steinbach, and R. Goldstein. 1999. An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis. J. Infect. Dis. 179:1197-1205.
91. Hudson, V. L., C. L. Wielinski, and W. E. Regelmann. 1993. Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years. J. Pediatr. 122:854-860.
92. Humphreys, H., D. Peckham, P. Patel, and A. Knox. 1994. Airborne dissemination of Burkholderia (Pseudomonas) cepacia from adult patients with cystic fibrosis. Thorax 49:1157-1159.
93. Humphreys, H., and D. Peckhman. 1996. Environmental sampling to detect Burkholderia cepacia in a cystic fibrosis outpatient clinic. Eur. J. Clin. Microbiol. Infect. Dis. 15:523-525.
94. Hunfeld, K. P., C. Schmidt, B. Krackhardt, H. G. Posselt, J. Bargon, Y. Yahaf, V. Schafer, V. Brade, and T. A. Wichelhaus. 2000. Risk of Pseudomonas aeruginosa cross-colonization in patients with cystic fibrosis within a holiday camp - a molecular-epidemiological study. Wien. Klin. Wochenschr. 112:329-333.
95. Hutchinson, G. R., S. Parker, J. A. Pryor, F. Duncan-Skingle, P. N. Hoffman, M. E. Hodson, M. E. Kaufmann, and T. L. Pitt. 1996. Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis. J. Clin. Microbiol. 34:584-587.
96. Isles, A., I. Maclusky, M. Corey, R. Gold, C. Prober, P. Fleming, and H. Levison. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104:206-210.
97. Jakobsson, B. M., A. B. Onnered, L. Hjelte, and B. Nystrom. 1997. Low bacterial contamination of nebulizers in home treatment of cystic fibrosis patients. J. Hosp. Infect. 36:201-207.
98. Jensen, E. T., B. Giwercman, B. Ojeniyi, J. M. Bangsborg, A. Hansen, C. Koch, N. E. Fiehn, and N. Hoiby. 1997. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis and the possible role of contamination by dental equipment. J. Hosp. Infect. 36:117-122.
99. Jernigan, J. A., M. A. Clemence, G. A. Stott, M. G. Titus, C. H. Alexander, C. M. Palumbo, and B. M. Farr. 1995. Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect. Control Hosp. Epidemiol. 16:686-696.
100. Jernigan, J. A., M. G. Titus, D. H. Groschel, S. Getchell-White, and B. M. Farr. 1996. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am. J. Epidemiol. 143:496-504.
101. Jones, A. M., J. R. Govan, C. J. Doherty, M. E. Dodd, B. J. Isalska, T. N. Stanbridge, and A. K. Webb. 2001. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 358:557-558.
102. Karapinar, M., and S. A. Gonul. 1992. Effects of sodium bicarbonate, vinegar, acetic and citric acids on growth and survival of Yersinia enterocolitica. Int. J. Food Microbiol. 16:343-347.
103. Kilby, J. M., P. H. Gilligan, J. R. Yankaskas, W. E. Highsmith, Jr., L. J. Edwards, and M. R. Knowles. 1992. Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest 102:70-75.
104. Kosorok, M. R., M. Jalaluddin, P. M. Farrell, G. Shen, C. E. Colby, A. Laxova, M. J. Rock, and M. Splaingard. 1998. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr. Pulmonol. 26:81-88.
105. Kosorok, M. R., L. Zeng, S. E. West, M. J. Rock, M. L. Splaingard, A. Laxova, C. G. Green, J. Collins, and P. M. Farrell. 2001. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr. Pulmonol. 32:277-287.
106. Kretzer, E. K., and E. L. Larson. 1998. Behavioral interventions to improve infection control practices. Am. J. Infect. Control 26:245-253.
107. Krzewinkski, J. W., C. D. Nguyen, J. M. Foster, and J. L. Burns. 2001. Use of random amplified polymorphic DNA polymerase chain reaction to determine the epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. J. Clin. Microbiol. 39:3597-3602.
108. Larson, E. L., E. Early, P. Cloonan, S. Sugrue, and M. Parides. 2000. An organizational climate intervention associated with increased handwashing and decreased nosocomial infections. Behav. Med. 26:14-22.
109. Leclair, J. M., J. Freeman, B. F. Sullivan, C. M. Crowley, and D. A. Goldmann. 1987. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. N. Engl. J. Med. 317:329-334.
110. Ledson, M. J., M. J. Gallagher, J. E. Corkill, C. A. Hart, and M. J. Walshaw. 1998. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax 53:432-436.
111. Lion, T. G., F. R. Adler, S. C. Fitz-Simmons, B. C. Cahill, J. R. Hibbs, and B. C. Marshall. 2001. Predictive 5-year survivorship model of cystic fibrosis. Am. J. Epidemiol. 153:345-352.
112. LiPuma, J. J. 1998. Burkholderia cepacia epidemiology and pathogenesis: implications for infection control. Curr. Opin. Pulm. Med. 4:337-341.
113. LiPuma, J. J. 1998. Burkholderia cepacia. Management issues and new insights. Clin. Chest Med. 19:473-486, vi.
114. LiPuma, J. J., S. E. Dasen, D. W. Nielson, R. C. Stern, and T. L. Stull. 1990. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 336:1094-1096.
115. LiPuma, J. J., K. A. Marks-Austin, D. S. Holsclaw, Jr., G. B. Winnie, P. H. Gilligan, and T. L. Stull. 1994. Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis. Pediatr. Infect. Dis. J. 13:716-719.
116. LiPuma, J. J., T. Spilker, T. Coenye, and C. F. Gonzalez. 2002. An epidemic Burkholderia cepacia complex strain identified in soil. Lancet 359:2002-2003.
117. LiPuma, J. J., T. Spilker, L. H. Gill, P. W. Campbell, III, L. Liu, and E. Mahenthiralingam. 2001. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am. J. Respir. Crit. Care Med. 164:92-96.
118. Luebbert, P. 2000. Home care, p 4-7. In P. Ja (cd.), Association for Professionals in Infection Control (APIC) text of infection control and epidemiology. APIC, Washington, D.C.
119. Macartney, K. K., M. H. Gorelick, M. L. Manning, R. L. Hodinka, and L. M. Bell. 2000. Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control. Pediatrics 106:520-526.
120. Maguire, C. P., J. P. Hayes, M. Hayes, J. Masterson, and M. X. FitzGerald. 1995. Three cases of pulmonary aspergilloma in adult patients with cystic fibrosis. Thorax 50:805-806.
121. Mahenthiralingam, E., M. E. Campbell, J. Foster, J. S. Lam, and D. P. Speert. 1996. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34:1129-1135.
122. Mahenthiralingam, E., D. A. Simpson, and D. P. Speert. 1997. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J. Clin. Microbiol. 35:808-816.
123. Mahenthiralingam, E., P. Vandamme, M. E. Campbell, D. A. Henry, A. M. Gravelle, L. T. Wong, A. G. Davidson, P. G. Wilcox, B. Nakielna, and D. P. Speert. 2001. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin. Infect. Dis. 33:1469-1475.
124. Mangram, A., and W. R. Jarvis. 1996. Nosocomial Burkholderia cepacia outbreaks and pseudo-outbreaks. Infect. Control Hosp. Epidemiol. 17:718-720.
125. Mastella, G., M. Rainisio, H. K. Harms, M. E. Hodson, C. Koch, J. Navarro, B. Strandvik, S. G. McKenzie, and the Epidemiologic Registry of Cystic Fibrosis. 2000. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Eur. Respir. J. 16:464-471.
126. McCallum, S. J., J. Corkill, M. Gallagher, M. J. Ledson, C. A. Hart, and M. J. Walshaw. 2001. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P. aeruginosa. Lancet 358:558-560.
127. McCallum, S. J., M. J. Gallagher, J. E. Corkill, C. A. Hart, M. J. Ledson, and M. J. Walshaw. 2002. Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives. Thorax 57:559-560.
128. McNeil, S. A., C. L. Foster, S. A. Hedderwick, and C. A. Kauffman. 2001. Effect of hand cleansing with antimicrobial soap or alcohol-based gel on microbial colonization of artificial fingernails worn by health care workers. Clin. Infect. Dis. 32:367-372.
129. Merritt, K., V. M. Hitchins, and S. A. Brown. 2000. Safety and cleaning of medical materials and devices. J. Biomed. Mater. Res. 53:131-136.
130. Mertz, J. J., L. Scharer, and J. H. McClement. 1967. A hospital outbreak of Klebsiella pneumonia from inhalation therapy with contaminated aerosol solutions. Am. Rev. Respir. Dis. 95:454-460.
131. Miall, L. S., N. T. McGinley, K. G. Brownlee, and S. P. Conway. 2001. Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis. Arch. Dis. Child. 84:160-162.
132. Miller, S. M., J. L. Parke, S. Bies, and J. J. LiPuma. 2000. Detection, recovery and identification of Burkholderia cepacia from the natural environment. Pediatr. Pulmonol. S20:288.
133. Moissenet, D., A. Baculard, M. Valcin, V. Marchand, G. Tournier, A. Garbarg-Chenon, and H. Vu-Thien. 1997. Colonization by Alcaligettes xylosoxidans in children with cystic fibrosis: a retrospective clinical study conducted by means of molecular epidemiological investigation. Clin. Infect. Dis. 24:274-275.
134. Moolenaar, R. L., J. M. Crutcher, V. H. San Joaquin, L. V. Sewell, L. C. Hutwagner, L. A. Carson, D. A. Robison, L. M. Smithee, and W. R. Jarvis. 2000. A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? Infect. Control Hosp. Epidemiol. 21:80-85.
135. Mortensen, J. E., M. C. Fisher, and J. J. LiPuma. 1995. Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infect. Control Hosp. Epidemiol. 16:30-32.
136. Navarro, J., M. Rainisio, H. K. Harms, M. E. Hodson, C. Koch, G. Mastella, B. Strandvik, S. G. McKenzie, and the European Epidemiologic Registry of Cystic Fibrosis. 2001. Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. Eur. Respir. J. 18:298-305.
137. Nelson, J. W., C. J. Doherty, P. H. Brown, A. P. Greening, M. E. Kaufmann, and J. R. Govan. 1991. Pseudomonas cepacia in inpatients with cystic fibrosis. Lancet 338:1525.
138. Nixon, G. M., D. S. Armstrong, R. Carzino, J. B. Carlin, A. Olinsky, C. F. Robertson, and K. Grimwood. 2001. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J. Pediatr. 138:699-704.
139. Ojeniyi, B., B. Frederiksen, and N. Hoiby. 2000. Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp. Pediatr. Pulmonol. 29:177-181.
140. Ojeniyi, B., U. S. Petersen, and N. Hoiby. 1993. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients. APMIS 101:168-175.
141. Oliver, A., L. Maiz, R. Canton, H. Escobar, F. Baquero, and E. Gomez-Mampaso. 2001. Nontuberculous mycobacteria in patients with cystic fibrosis. Clin. Infect. Dis. 32:1298-1303.
142. Olivier, K., D. Weber, J.-H. Lee, A. Handler, G. Tudor, P. Molina, J. Tomashefski, and M. Knowles. 2003. Nontuberculosis mycobacteria 11: nested-cohort study of impact on cystic fibrosis lung disease. Am. J. Respir. Crit. Care Med. 167:835-840.
143. Olivier, K. N., D. J. Weber, R. J. Wallace, A. R. Faiz, J.-H. Lee, Y. Zhang, B. A. Brown-Elliot, A. Handler, R. W. Wilson, M. S. Schechter, L. J. Edwards, S. Chakraborti, and M. R. Knowles. 2003. Nontuberculosis mycobacteria I: multicenter prevalence study in cystic fibrosis. Am. J. Respir. Crit. Care Med. 167:828-834.
144. Olivier, K. N., J. R. Yankaskas, and M. R. Knowles. 1996. Nontuberculous mycobacterial pulmonary disease in cystic fibrosis. Semin. Respir. Infect. 11:272-284.
145. Pankhurst, C. L., V. E. Harrison, and J. Philpott-Howard. 1995. Evaluation of contamination of the dentist and dental surgery environment with Burkholderia (Pseudomonas) cepacia during treatment of children with cystic fibrosis. Int. J. Paediatr. Dent. 5:243-247.
146. Parad, R. B., C. J. Gerard, D. Zurakowski, D. P. Nichols, and G. B. Pier. 1999. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Infect. Immun. 67:4744-4750.
147. Parry, M. F., B. Grant, M. Yukna, D. Adler-Klein, G. X. McLeod, R. Taddonio, and C. Rosenstein. 2001. Candida osteomyelitis and diskitis after spinal surgery: an outbreak that implicates artificial nail use. Clin. Infect. Dis. 32:352-357.
148. Passaro, D. J., L. Waring, R. Armstrong, F. Bolding, B. Bouvier, J. Rosenberg, A. W. Reingold, M. McQuitty, S. M. Philpott, W. R. Jarvis, S. B. Werner, L. S. Tompkins, and D. J. Vugia. 1997. Postoperative Serratia marcescens wound infections traced to an out-of-hospital source. J. Infect. Dis. 175:992-995.
149. Paul, M. L., M. A. Pegler, and R. A. Benn. 1998. Molecular epidemiology of Burkholderia cepacia in two Australian cystic fibrosis centres. J. Hosp. Infect. 38:19-26.
150. Pedersen, S. S., T. Jensen, N. Hoiby, C. Koch, and E. W. Flensborg. 1987. Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients. Acta Paediatr. Scand. 76:955-961.
151. Pedersen, S. S., C. Koch, N. Hoiby, and K. Rosendal. 1986. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J. Antimicrob. Chemother. 17:505-516.
152. Pegues, D. A., L. A. Carson, O. C. Tablan, S. C. Fitz-Simmons, S. B. Roman, J. M. Miller, W. R. Jarvis, and the Summer Camp Study Group. 1994. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. J. Pediatr. 124:694-702.
153. Pegues, D. A., D. V. Schidlow, O. C. Tablan, L. A. Carson, N. C. Clark, and W. R. Jarvis. 1994. Possible nosocomial transmission of Pseudomonas cepacia in patients with cystic fibrosis. Arch. Pediatr. Adolesc. Med. 148:805-812.
154. Perl, T. M., J. J. Cullen, R. P. Wenzel, M. B. Zimmerman, M. A. Pfaller, D. Sheppard, J. Twombley, P. P. French, and L. A. Herwaldt. 2002. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N. Engl. J. Med. 346:1871-1877.
155. Perl, T. M., and M. C. Roy. 1995. Postoperative wound infections: risk
156. Piedra, P. A., S. Grace, A. Jewell, S. Spinelli, D. Bunting, D. A. Hogerman, F. Malinoski, and P. W. Hiatt. 1996. Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis. Pediatr. Infect. Dis. J. 15:23-31.
157. Pitchford, K. C., M. Corey, A. K. Highsmith, R. Perlman, R. Bannatyne, R. Gold, H. Levison, and E. L. Ford-Jones. 1987. Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment. J. Pediatr. 111:212-216.
158. Pittet, D., S. Hugonnet, S. Harbarth, P. Mourouga, V. Sauvan, S. Touveneau, T. V. Perneger, and the Infection Control Programme. 2000. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 356:1307-1312.
159. Pribble, C. G., P. G. Black, J. A. Bosso, and R. B. Turner. 1990. Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections. J. Pediatr. 117:200-204.
160. Ramsey, A. H., P. Skonieczny, D. T. Coolidge, T. A. Kurzynski, M. E. Proctor, and J. P. Davis. 2001. Burkholderia cepacia lower respiratory tract infection associated with exposure to a respiratory therapist. Infect. Control. Hosp. Epidemiol. 22:423-426.
161. Ramsey, B. W., E. J. Gore, A. L. Smith, M. K. Cooney, G. J. Redding, and H. Foy. 1989. The effect of respiratory viral infections on patients with cystic fibrosis. Am. J. Dis. Child. 143:662-668.
162. Reboli, A. C., R. Koshinski, K. Arias, K. Marks-Austin, D. Stieritz, and T. L. Stull. 1996. An outbreak of Burkholderia cepacia lower respiratory tract infection associated with contaminated albuterol nebulization solution. Infect. Control Hosp. Epidemiol. 17:741-743.
163. Romling, U., B. Fiedler, J. Bosshammer, D. Grothues, J. Greipel, H. von der Hardt, and B. Tummler. 1994. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J. Infect. Dis. 170:1616-1621.
164. Romling, U., J. Wingender, H. Muller, and B. Tummler. 1994. A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl. Environ. Microbiol. 60:1734-1738.
165. Rosaspina, S., G. Salvatorelli, and D. Anzanel. 1994. The bactericidal effect of microwaves on Mycobacterium bovis dried on scalpel blades. J. Hosp. Infect. 26:45-50.
166. Rosaspina, S., G. Salvatorelli, D. Anzanel, and R. Bovolenta. 1994. Effect of microwave radiation on Candida albicans. Microbios 78:55-59.
167. Rosenfeld, M., R. Davis, S. Fitz-Simmons, M. Pepe, and B. Ramsey. 1997. Gender gap in cystic fibrosis mortality. Am. J. Epidemiol. 145:794-803.
168. Rosenfeld, M., P. Joy, C. D. Nguyen, J. W. Krzewinkski, and J. L. Burns. 2001. Cleaning home nebulizers used by patients with cystic fibrosis: is rinsing with tap water enough? J. Hosp. Infect. 49:229-230.
169. Rutala, W. A., S. L. Barbee, N. C. Aguiar, M. D. Sobsey, and D. J. Weber. 2000. Antimicrobial activity of home disinfectants and natural products against potential human pathogens. Infect. Control Hosp. Epidemiol 21:33-38.
170. Rutala, W. A., and D. J. Weber. 1998. Principles of disinfecting patient-care items, p. 133-149. In W. A. Rutala (ed.), Disinfection, sterilization and antisepsis in health care. Polyscience Publications, Champlain, N.Y.
171. Rutala, W. A., D. J. Weber, and HICPAC. 2003. Guideline for disinfection and sterilization in healthcare facilities. Centers for Disease Control and Prevention, Atlanta, Ga.
172. Saiman, L., F. Mehar, W. W. Niu, H. C. Neu, K. J. Shaw, G. Miller, and A. Prince. 1996. Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin. Infect. Dis. 23:532-537.
173. Saiman, L., and J. Siegel. 2003. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Am. J. Infect. Control 31:S6-S62.
174. Saiman, L., and J. Siegel for the Cystic Fibrosis Foundation. 2003. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect. Control Hosp. 24:S6-52.
175. Sanborn, M. R., S. K. Wan, and R. Bulard. 1982. Microwave sterilization of plastic tissue culture vessels for reuse. Appl. Environ. Microbiol. 44:960-964.
176. Sanders, C. V., Jr., J. P. Luby, W. G. Johanson, Jr., J. A. Barnett, and J. P. Sanford. 1970. Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak. Ann. Intern. Med. 73:15-21.
177. Schlichting, C., C. Branger, J. M. Fournier, W. Witte, A. Boutonnier, C. Wolz, P. Goullet, and G. Doring. 1993. Typing of Staphylococcus aureus by pulsed-field gel electrophoresis, zymotyping, capsular typing, and phage typing: resolution of clonal relationships. J. Clin. Microbiol. 31:227-232.
178. Smith, D. L., L. B. Gumery, E. G. Smith, D. E. Stableforth, M. E. Kaufmann, and T. L. Pitt. 1993. Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J. Clin. Microbiol. 31:3017-3022.
179. Smith, M. J., J. Efthimiou, M. E. Hodson, and J. C. Batten. 1984. Mycobacterial isolations in young adults with cystic fibrosis. Thorax 39:369-375.
180. Smyth, A. R., R. L. Smyth, C. Y. Tong, C. A. Hart, and D. P. Heaf. 1995. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch. Dis. Child. 73:117-120.
181. Speert, D. P., and M. E. Campbell. 1987. Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis. J. Hosp. Infect. 9:11-21.
182. Speert, D. P., M. E. Campbell, D. A. Henry, R. Milner, F. Taha, A. Gravelle, A. G. Davidson, L. T. Wong, and E. Mahenthiralingam. 2002. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. Am. J. Respir. Crit. Care Med. 166:988-993.
183. Speert, D. P., D. Henry, P. Vandamme, M. Corey, and E. Mahenthiralingam. 2002. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis in Canada: geographical distribution and clustering of strains. Emerg. Infect. Dis. 8:181-187.
184. Speert, D. P., D. Lawton, and S. Damm. 1982. Communicability of Pseudomonas aeruginosa in a cystic fibrosis summer camp. J. Pediatr. 101:227-228.
185. Stableforth, D. E., and D. L. Smith. 1994. Pseudomonas cepacia in cystic fibrosis. Thorax 49:629-630.
186. + Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat. Med. 1:661-666.
187. Tablan, O. C., T. L. Chorba, D. V. Schidlow, J. W. White, K. A. Hardy, P. H. Gilligan, W. M. Morgan, L. A. Carson, W. J. Martone, J. M. Jason, and W. Jarvis. 1985. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J. Pediatr. 107:382-387.
188. Tablan, O. C., W. J. Martone, C. F. Doershuk, R. C. Stern, M. J. Thomassen, J. D. Klinger, J. W. White, L. A. Carson, and W. R. Jarvis. 1987. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest 91:527-532.
189. Talmaciu, I., L. Varlotta, J. Mortensen, and D. V. Schidlow. 2000. Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis. Pediatr. Pulmonol. 30:10-15.
190. Thomas, S. R., K. M. Gyi, H. Gaya, and M. E. Hodson. 1998. Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre. J. Hosp. Infect. 40:203-209.
191. Thomassen, M. J., C. A. Demko, C. F. Doershuk, R. C. Stern, and J. D. Klinger. 1986. Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am. Rev. Respir. Dis. 134:669-671.
192. Tomashefski, J. F., Jr., R. C. Stern, C. A. Demko, and C. F. Doershuk. 1996. Nontuberculous mycobacteria in cystic fibrosis. An autopsy study. Am. J. Respir. Crit. Care Med. 154:523-528.
193. Torrens, J. K., P. Dawkins, S. P. Conway, and E. Moya. 1998. Non-tuberculous mycobacteria in cystic fibrosis. Thorax 53:182-185.
194. Valdezate, S., A. Vindel, L. Maiz, F. Baquero, H. Escobar, and R. Canton. 2001. Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998. Emerg. Infect. Dis. 7:113-121.
195. Vandamme, P., B. Holmes, T. Coenye, J. Goris, E. Mahenthiralingam, J. LiPuma, and J. R. Govan. 2003. Burkholderia cenocepacia sp. nov. - a new twist to an old story. Res. Microbiol. 154:91-96.
196. Vandamme, P., B. Holmes, M. Vancanneyt, T. Coenye, B. Hoste, R. Coopman, H. Revets, S. Lauwers, M. Gillis, K. Kersters, and J. R. Govan. 1997. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int. J. Syst. Bacteriol. 47:1188-1200.
197. von Eiff, C., K. Becker, K. Machka, H. Stammer, G. Peters, and the Study Group. 2001. Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344:11-16.
198. Vu-Thien, H., D. Moissenet, M. Valcin, C. Dulot, G. Tournier, and A. Garbarg-Chenon. 1996. Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center. Eur. J. Clin. Microbiol. Infect. Dis. 15:876-879.
199. Walsh, N. M., A. A. Casano, L. P. Manangan, R. L. Sinkowitz-Cochran, and W. R. Jarvis. 2002. Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis. J. Pediatr. 141:512-517.
200. Wang, E. E., C. G. Prober, B. Manson, M. Corey, and H. Levison. 1984. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N. Engl. J. Med. 311:1653-1658.
201. Whiteford, M. L., J. D. Wilkinson, J. H. McColl, F. M. Conlon, J. R. Michie, T. J. Evans, and J. Y. Paton. 1995. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax 50:1194-1198.
202. Williams, T. 1997. Evaluation of antimicrobial sensitivity patterns as markers of Pseudomonas aeruginosa cross-infection at a cystic fibrosis clinic. Br. J. Biomed. Sci. 54:181-185.
203. Wolz, C., G. Kiosz, J. W. Ogle, M. L. Vasil, U. Schaad, K. Botzenhart, and G. Doring. 1989. Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe. Epidemiol. Infect. 102:205-214.
204. Zimakoff, J., N. Hoiby, K. Rosendal, and J. P. Guilbert. 1983. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic. J. Hosp. Infect. 4:31-40.